Marketing & Strategy

91% of clinicians use reprints to improve patient care

Health Industry Hub | November 18, 2019 |
[Total: 1    Average: 4/5]

For doctors, getting patient care right can be a case of life or death. They need to stay up to date with the latest research in their field, but that takes time – something that’s in short supply. It would seem logical, then, that doctors would welcome relevant and important medical studies in their inboxes, which they could use when diagnosing and treating patients.

With this in mind, pharmaceutical companies often sponsor and distribute reprints – republished versions of medical studies that doctors can use in their work, which are emailed to them for free.

Elsevier recently carried out an APAC based survey of physicians (download below) to find out whether doctors find these reprints useful, and to what extent reprints impact their work with patients. Carried out in December 2018 and January 2019, the survey asked physicians to share their experience using reprints.

The aim of the research was to understand how primary care physicians and specialists access and use scientific articles in reprint format, and why they choose certain content.

The responses provided insights across care areas: 343 physicians from APAC responded; about 80 percent were medical specialists and 20 percent were general practitioners.

Download the medical reprints infographic


About the author

About the author

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Nam luctus finibus scelerisque. Nunc bibendum ipsum sed augue fringilla fringilla. Nullam at consectetur leo. Praesent viverra rutrum porta. Quisque vitae mi vel purus vulputate tincidunt. Class aptent taciti sociosqu ad litora torquent per conubia nostra, per inceptos himenaeos. Suspendisse et mi quis nisi rhoncus feugiat at ac tellus. Sed aliquam sodales nulla ac auctor. Sed pretium lobortis purus accumsan ullamcorper. Phasellus sodales vel odio in lobortis. Duis maximus sagittis bibendum. Interdum et malesuada fames ac ante ipsum primis in faucibus. Nunc dictum tincidunt ipsum in vestibulum. Donec ut sem consectetur, aliquam quam vitae, pharetra orci. Nam egestas non velit eu rhoncus. Duis congue neque non lacus tincidunt porta. Vestibulum ultricies pulvinar sem, molestie congue dui aliquet non.
  • Ut imperdiet leo id lorem fermentum consectetur.
  • Ut vitae orci et dui varius tincidunt.
  • Ut id magna non libero vestibulum pharetra ac faucibus nulla.
Aliquam erat volutpat. Vestibulum vitae varius diam. Nulla eget congue ante. Nunc ullamcorper sagittis augue vel dictum. Mauris finibus nibh ut pulvinar auctor. Vestibulum ut faucibus nisi. Orci varius natoque penatibus et magnis dis parturient montes, nascetur ridiculus mus. Quisque porta tortor ac justo malesuada elementum. Nulla tellus ante, cursus nec ex sit amet, suscipit bibendum arcu. Duis posuere orci dui, et mollis enim dictum at. Sed ullamcorper, sapien ut vulputate viverra, sem purus porttitor tellus, nec mattis mauris ligula sed risus. Nulla sagittis id ipsum eu mattis. Link to full profile

Medical

Medical Pharma Biotech MedTech - Medical researchers support interim budget measures and urge longer-term sustainability - Research Australia

Medical researchers support interim budget measures and urge longer-term sustainability

Health Industry Hub | September 28, 2020 |

Medical News: The $700 million bail-out package for university researchers flagged for consideration in the upcoming federal budget would be […]

More


Digital & Innovation

Healthcare Technology Digital Innovations - Pfizer Australia backs digital health start-ups, an interview with Country Medical Director Dr Krishan Thiru

Pfizer Australia backs digital health start-ups, an interview with Country Medical Director

Health Industry Hub | September 28, 2020 |

Digital & Innovation: The recent Innovate Health virtual event aimed at navigating commercialisation, accelerating growth and uptake of digital health […]

More


News & Trends - Medical Technology

MedTech News - Documentation of COVID-19 screening fell short of national imperative in Australian hospitals

Documentation of COVID-19 screening fell short of national imperative in Australian hospitals, says new study

Health Industry Hub | September 28, 2020 |

MedTech News: New Australian research on COVID-19 screening of hospital patients during the first wave of the pandemic found that […]

More


News & Trends - Pharmaceuticals

Pharma News - Roche's haemophilia treatment available at no cost to patients

Roche’s haemophilia treatment available at no cost to patients

Health Industry Hub | September 28, 2020 |

Pharma News: The Australian government have agreed to fund a new treatment for haemophilia patients, through the national blood arrangements. […]

More